What is the current Medical Molecular Imaging market size?

The Medical Molecular Imaging market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Medical Molecular Imaging market?

Increasing demand for diagnostic imaging and rising incidence of chronic diseases are key drivers.

What are the major challenges facing the market?

High costs of equipment and procedures are major challenges facing the Medical Molecular Imaging market.

Which regions are leading the Medical Molecular Imaging market?

North America and Europe are regional leaders, driven by advanced healthcare infrastructure.

Who are the top companies in the Medical Molecular Imaging market?

Top companies include GE Healthcare, Siemens Healthineers, and Philips Healthcare, driving innovation.

What future opportunities exist in the Medical Molecular Imaging market?

Emerging economies and increasing adoption of hybrid imaging modalities present future opportunities.

How is technology impacting the Medical Molecular Imaging market?

Advances in artificial intelligence and machine learning are enhancing image analysis and diagnosis.

What is the current regulatory landscape for the market?

Stringent regulatory frameworks and safety standards govern the Medical Molecular Imaging market.

How will the market evolve in the next 5 years?

The market will evolve through increased adoption of molecular imaging modalities and personalized medicine.

What Is the Global Medical Molecular Imaging Market Worth in 2026?

Medical Molecular Imaging by Application (Oncology, Cardio and Vascular, Neurology, Others), by Types (MRI, CT, PET, SPECT, Ultrasound), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Medical Molecular Imaging Market Size | CAGR 0.075 Forecast 2033

What Is the Global Medical Molecular Imaging Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Medical Molecular Imaging Market Overview

The Medical Molecular Imaging market refers to the use of molecular imaging techniques to visualize and quantify biological processes at the molecular and cellular levels. As a crucial component of modern healthcare, the Medical Molecular Imaging market size is estimated to be around $7.3 billion in 2025. The growth outlook for the Medical Molecular Imaging market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2026-2033. This industry expansion is driven by factors such as the increasing prevalence of chronic diseases, advances in technology, and rising demand for diagnostic imaging procedures. The scope of the Medical Molecular Imaging market includes various techniques such as Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI).

Loading chart…

The growth of the Medical Molecular Imaging market is influenced by key forces such as technology shifts, regulations, and consumer behavior. The largest region in the Medical Molecular Imaging market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the increasing adoption of advanced imaging technologies, rising demand for diagnostic procedures, and growing awareness about the benefits of molecular imaging. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, opportunities, and challenges shaping the Medical Molecular Imaging landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cardiarc; Digirad; Gamma Medica; GE; Gvi Medical Devices; Hitachi; Mediso; CMR Naviscan; Neurologica; Neusoft; BC Technical; Philips; Positron; Siemens; Biosensors International; Toshiba; Trivitron Healthcare; Molecular Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Molecular Imaging market is poised for significant growth, driven by advancing technologies and increasing demand for non-invasive diagnostic procedures. The growth forecast for the Medical Molecular Imaging market size is expected to be substantial, with key drivers influencing the market's trajectory.

Growth Drivers2 items

Advances in PET and SPECT technologies are expanding the range of applications for Medical Molecular Imaging, allowing for earlier disease detection and more effective treatment monitoring

The growing prevalence of chronic diseases, such as cancer and neurological disorders, is driving demand for Medical Molecular Imaging procedures, contributing to the overall growth forecast of the Medical Molecular Imaging market size

Restraints2 items

High equipment costs and limited availability of Medical Molecular Imaging technologies in developing regions are hindering market growth, affecting the overall Medical Molecular Imaging market size and growth forecast

Regulatory requirements and reimbursement challenges are also constraining the adoption of Medical Molecular Imaging technologies, particularly in markets with strict healthcare regulations

Opportunities2 items

The integration of Artificial Intelligence and Machine Learning with Medical Molecular Imaging is creating new opportunities for improved image analysis and diagnostic accuracy, driving growth in the Medical Molecular Imaging market

The increasing focus on Personalized Medicine is driving demand for targeted and tailored Medical Molecular Imaging procedures, contributing to the growth forecast of the Medical Molecular Imaging market size

Challenges2 items

The cybersecurity of Medical Molecular Imaging data is a growing concern, as the use of connected devices and electronic health records increases, posing a challenge to the Medical Molecular Imaging market

The need for standardized protocols and guidelines for Medical Molecular Imaging procedures is a significant challenge, as it can impact the quality and consistency of diagnostic results, affecting the Medical Molecular Imaging market size and growth forecast

Market Segmentation

Loading chart…

The Medical Molecular Imaging segmentation by Application is a crucial aspect of the market taxonomy. This segment is divided into subtypes, including Oncology, Cardiology, Neurology, and Others. Each of these subtypes contributes to the overall market size, with Oncology being the largest contributor due to the increasing incidence of cancer and the growing demand for early diagnosis and treatment. The Application segment is expected to drive the growth of the Medical Molecular Imaging market, with a significant share of the market revenue coming from this segment.

The Medical Molecular Imaging market can also be segmented by Types, which includes subtypes such as Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Magnetic Resonance Imaging (MRI), and Others. Each of these subtypes has its own unique characteristics and applications, and they contribute to the overall market size in different ways. For instance, PET is widely used in Oncology and Neurology applications, while SPECT is commonly used in Cardiology applications. Understanding the different Types and their subtypes is essential for analyzing the Medical Molecular Imaging market taxonomy and identifying opportunities for growth and development.

Medical Molecular Imaging Segmentation Breakdown11 items

Application

Oncology

Cardio and Vascular

Neurology

Others

Types

MRI

PET

SPECT

Ultrasound

Regional Insights

Loading chart…

The Medical Molecular Imaging market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced imaging technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - ecosystem maturity, high demographics awareness, and established infrastructure; Europe - increasing adoption of hybrid imaging modalities, favorable policies, and growing investments in research and development; Asia Pacific - rising demographics, expanding infrastructure, and increasing adoption of medical imaging technologies; Latin America - growing investments in healthcare, increasing adoption of medical imaging technologies, and favorable policies; Middle East & Africa - increasing adoption of medical imaging technologies, growing investments in healthcare infrastructure, and rising demographics.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing adoption of medical imaging technologies and significant investments in healthcare infrastructure. The Medical Molecular Imaging market is expected to witness significant growth in the coming years, driven by factors such as increasing demographics, advancing technologies, and favorable policies.

Competitive Landscape

The Medical Molecular Imaging market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Medical Molecular Imaging competitive landscape is driven by the need for companies to differentiate themselves through these levers. Global players tend to focus on high-end products and premium pricing, while local companies often target cost-sensitive markets with more affordable options.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation can be achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on specific strategic areas, such as:

Cardiarc: regional expansion

Digirad: premium pricing

GE: innovation pipeline

Gvi Medical Devices: local manufacturing

Hitachi: vertical integration

Philips: OEM tie-ups

Key Medical Molecular Imaging Companies18 items

Cardiarc

Digirad

Gamma Medica

Gvi Medical Devices

Hitachi

Mediso

CMR Naviscan

Neurologica

Neusoft

BC Technical

Philips

Positron

Siemens

Biosensors International

Toshiba

Trivitron Healthcare

Molecular Devices

Market Ecosystem

The Medical Molecular Imaging ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem is characterized by a series of interactions, where value is created and captured through the development, integration, and delivery of medical molecular imaging technologies and services. The ecosystem can be broadly segmented into three main categories: upstream technology providers and suppliers, midstream integrators and channels, and downstream end users.

Technology providers — develop imaging technologies

OEMs / manufacturers — produce imaging equipment

System integrators / EPCs — integrate imaging systems

Distributors / channel partners — distribute imaging products

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize imaging technologies for diagnosis

Regulators/standards bodies — establish guidelines and approvals

In the Medical Molecular Imaging ecosystem, control points are often held by regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as access to raw materials, and standards, which can impact the development and delivery of imaging technologies. A thorough value chain analysis is necessary to understand the complex interactions within the ecosystem, including switching costs, partnerships, and interoperability requirements, which can vary by region due to diverse regulatory environments.

Recent Industry Insights

The Medical Molecular Imaging industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and increasing demand for diagnostic imaging. Recently, there have been notable partnerships between leading companies to develop innovative imaging agents and technologies. For instance, major players have collaborated to enhance the accuracy and efficiency of molecular imaging procedures.

Furthermore, the industry has seen a surge in product launches and mergers & acquisitions, with companies focusing on expanding their portfolios and strengthening their market presence. Regulatory changes have also played a crucial role in shaping the Medical Molecular Imaging industry, with authorities implementing new guidelines to ensure the safe use of imaging agents. As a result, the industry is expected to experience significant growth, driven by shifting consumer and enterprise trends towards personalized medicine and precision diagnostics.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Medical Molecular Imaging market. The market attractiveness is high due to increasing demand for early disease diagnosis and treatment. The competitive intensity is moderate, with key players focusing on innovation and partnerships. The long-term Medical Molecular Imaging market outlook is promising, driven by advances in technology and growing healthcare expenditure. The innovation landscape is rapidly evolving, with emerging trends such as personalized medicine and artificial intelligence.

Key Insights2 items

Demand-supply balance is expected to remain stable, with suppliers investing in capacity expansion

Key risk factors include regulatory changes and reimbursement challenges

11 items

1. Executive Summary

2. Medical Molecular Imaging Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Molecular Imaging Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Molecular Imaging Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oncology

6.1.2. Cardio and Vascular

6.1.3. Neurology

6.1.4. Others

6.2. Global Medical Molecular Imaging Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. MRI

6.2.2. CT

6.2.3. PET

6.2.4. SPECT

6.2.5. Ultrasound

6.3. Global Medical Molecular Imaging Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Molecular Imaging Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Molecular Imaging Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Molecular Imaging Market Competition by Key Manufacturers

8.1. Global Medical Molecular Imaging Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Molecular Imaging: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cardiarc

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Digirad

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Gamma Medica

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GE

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Gvi Medical Devices

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hitachi

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Mediso

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. CMR Naviscan

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Neurologica

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Neusoft

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BC Technical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Philips

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Positron

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Siemens

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Biosensors International

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Toshiba

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Trivitron Healthcare

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Molecular Devices

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Molecular Imaging Market

Figure 4: Global Medical Molecular Imaging Market: Drivers

Figure 5: Global Medical Molecular Imaging Market: Challenges

Figure 6: Global Medical Molecular Imaging Market: Trends

Figure 7: Global Medical Molecular Imaging Market: Opportunity

Figure 8: Global Medical Molecular Imaging Market: Restraint

Figure 9: Global Medical Molecular Imaging Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Molecular Imaging Market Value (USD Million) By Region

Figure 15: Global Medical Molecular Imaging Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Molecular Imaging Market Value (USD Million) By Region

Figure 23: Global Medical Molecular Imaging Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Molecular Imaging Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Molecular Imaging Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Molecular Imaging Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Molecular Imaging Market Value (USD Million) By Region

Table 10: Global Medical Molecular Imaging Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Molecular Imaging Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Molecular Imaging Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Molecular Imaging Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cardiarc Basic Information And Sales Area

Table 31: Cardiarc. Products Portfolio

Table 32: Digirad Basic Information And Sales Area

Table 33: Digirad. Products Portfolio

Table 34: Gamma Medica Basic Information And Sales Area

Table 35: Gamma Medica. Products Portfolio

Table 36: GE Basic Information And Sales Area

Table 37: GE. Products Portfolio

Table 38: Gvi Medical Devices Basic Information And Sales Area

Table 39: Gvi Medical Devices. Products Portfolio

Table 40: Hitachi Basic Information And Sales Area

Table 41: Hitachi. Products Portfolio

Table 42: Mediso Basic Information And Sales Area

Table 43: Mediso. Products Portfolio

Table 44: CMR Naviscan Basic Information And Sales Area

Table 45: CMR Naviscan. Products Portfolio

Table 46: Neurologica Basic Information And Sales Area

Table 47: Neurologica. Products Portfolio

Table 48: Neusoft Basic Information And Sales Area

Table 49: Neusoft. Products Portfolio

Table 50: BC Technical Basic Information And Sales Area

Table 51: BC Technical. Products Portfolio

Table 52: Philips Basic Information And Sales Area

Table 53: Philips. Products Portfolio

Table 54: Positron Basic Information And Sales Area

Table 55: Positron. Products Portfolio

Table 56: Siemens Basic Information And Sales Area

Table 57: Siemens. Products Portfolio

Table 58: Biosensors International Basic Information And Sales Area

Table 59: Biosensors International. Products Portfolio

Table 60: Toshiba Basic Information And Sales Area

Table 61: Toshiba. Products Portfolio

Table 62: Trivitron Healthcare Basic Information And Sales Area

Table 63: Trivitron Healthcare. Products Portfolio

Table 64: Molecular Devices Basic Information And Sales Area

Table 65: Molecular Devices. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Medical Molecular Imaging Market Value (USD Million) By Region

Table 71: Global Medical Molecular Imaging Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Molecular Imaging Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cardiarc; Digirad; Gamma Medica; GE; Gvi Medical Devices; Hitachi; Mediso; CMR Naviscan; Neurologica; Neusoft; BC Technical; Philips; Positron; Siemens; Biosensors International; Toshiba; Trivitron Healthcare; Molecular Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options